A subcommittee of the Nuclear Regulatory Commission’s Advisory Committee on Reactor Safeguards met Thursday to discuss the licensing progress for Northwest Medical Isotopes’ (NWMI) planned production facility.
Northwest is one of several U.S. companies aiming…
SUBSCRIBER ACCESS
Thank you for visiting
RadWaste Monitor!
You must be logged in as a subscriber to view this page.





